Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $2.3 million.

  • Zhengye Biotechnology Holding's Other Non-Current Assets changed N/A to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2024, which is 18274.69% up from last year.
  • As of Q2 2025, Zhengye Biotechnology Holding's Other Non-Current Assets stood at $2.3 million.
  • Zhengye Biotechnology Holding's 5-year Other Non-Current Assets high stood at $2.6 million for Q4 2024, and its period low was $903323.6 during Q4 2023.
  • Over the past 3 years, Zhengye Biotechnology Holding's median Other Non-Current Assets value was $2.3 million (recorded in 2025), while the average stood at $2.0 million.
  • Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Other Non-Current Assets was 18816.42% (2024), while the steepest drop was 18816.42% (2024).
  • Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Other Non-Current Assets stood at $903323.6 in 2023, then soared by 188.16% to $2.6 million in 2024, then dropped by 9.82% to $2.3 million in 2025.
  • Its Other Non-Current Assets was $2.3 million in Q2 2025, compared to $2.6 million in Q4 2024 and $903323.6 in Q4 2023.